Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v3-EN
Language French English
Date Updated 2023-06-29 2023-03-03
Drug Identification Number 02125226 02125226
Brand name NIDAGEL NIDAGEL
Common or Proper name NIDAGEL NIDAGEL
Company Name BAUSCH HEALTH, CANADA INC. BAUSCH HEALTH, CANADA INC.
Ingredients METRONIDAZOLE METRONIDAZOLE
Strength(s) 0.75% 0.75%
Dosage form(s) GEL GEL
Route of administration VAGINAL VAGINAL VAGINAL VAGINAL
Packaging size 70g 70g
ATC code G01AF G01AF
ATC description ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST. ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.
Reason for shortage Shortage of an inactive ingredient or component. Shortage of an inactive ingredient or component.
Anticipated start date 2023-03-31 2023-03-31
Actual start date 2023-03-20
Estimated end date 2023-06-30 2023-06-16
Actual end date 2023-06-26
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments